Diabetes and cancer: therapeutic implications
Authors:
Open Access
- 23 January 2026
- journal article
- review article
- Published by Springer Nature in Cardio-Oncology
- Vol. 12 (1)
Abstract
The growing coexistence of diabetes and cancer contributes substantially to global morbidity and mortality. Beyond the independent burden of each disease,Keywords
Funding Information
- National Center for Advancing Translational Sciences (KL2TR001446)
This publication has 180 references indexed in Scilit:
- NT-ProBNP and High-Sensitivity Troponin T as Screening Tests for Subclinical Chronic Heart Failure in a General PopulationESC Heart Failure, 2022
- Diabetes Mellitus Exacerbates Post-Myocardial Infarction Heart Failure by Reducing Sarcolipin Promoter MethylationESC Heart Failure, 2020
- Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical TrialJAMA Cardiology, 2019
- Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protectionMedicinal Research Reviews, 2018
- Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart diseaseDiabetologia, 2017
- The mechanisms of action of metforminDiabetologia, 2017
- Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational studyInternational Journal of Cancer, 2017
- Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled TrialEuropean Journal of Heart Failure, 2016
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection FractionJAMA, 2016
- Metformin in Patients With Type 2 Diabetes and Kidney DiseaseJAMA, 2014